👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Dow slumps as Treasury yields jump after hot inflation report cools rate-cut bets

Published 02/13/2024, 08:32 AM
Updated 02/14/2024, 03:38 AM
© Reuters.
US500
-
DJI
-
NVDA
-
LCO
-
CL
-
1YMZ24
-
NQZ24
-
IXIC
-

Investing.com -- The Dow slumped on Tuesday as Treasury yields surged after a hotter-than-expected inflation report cooled expectations for a sooner and more aggressive Federal Reserve's rate cutting cycle. 

By 14:33 ET (19:33 GMT), the Dow futures fell 688 points, or 1.8%, the S&P 500 futures contract fell 1.7%, and the Nasdaq 100 futures clumped 1.9%.

Inflation comes in hot to cool Fed rate cut optimism, pushing Treasury yields higher

Headline annual U.S. inflation slowed to 3.1% pace in January, from 3.4% a month earlier, but that was still above economists estimates of 2.9%.

Core inflation, which the Fed watches more closely as it strips out volatile items like food and fuel, remained at the same annual pace of 3.9% posted in December, but was expected to slow to a 3.7% pace.

Treasury yields jumped, with the 2-year Treasury yield rising 17 basis points to 4.637%, while the yield on the 10-year Treasury surging 14 basis points to 4.316%. 

The hotter inflation report was driven by the "lumpy shelter/rent component," RBC said, adding that  broader signs of reacceleration in inflation pressures" as well as a strong labor market "are reinforcing the risk that the Fed won't need (or be able to) pivot to interest rate cuts as quickly or aggressively as previously expected."

With a March rate cut all but priced out, investors cut their bets on a May rate cut to 31.6% from nearly 50% the prior day, according to Investing.com's Fed Rate Monitor Tool. 

Coca-Cola delivers earnings beat, but peak pricing power worries weigh; Biogen, Hasbro stumble on earning stage

Coca-Cola Co (NYSE:KO) fell nearly 1% after better-than-expected fourth-quarter results and guidance was cast aside by worries about waning pricing power as top-line sales growth from a year earlier.

Biogen (NASDAQ:BIIB) fell more than 7%  after the company reported lower-than-anticipated profit and revenue in its latest quarter, driven by weaker sales across multiple products including Vumerity, Spinraza amid competition and pricing pressures. 

Hasbro (NASDAQ:HAS) also stumbled on the earnings stage, after its fourth-quarter results and guidance missed Wall Street estimates, sending its shares more than 3% lower.

The toy maker's performance was dragged by it entertainment segment, which came under pressure from industry strikes, and a losses owing to goodwill and intangible asset impairment charges.

Nvidia gets a boost ahead of quarterly earnings next week

NVIDIA Corporation (NASDAQ:NVDA) sidestepped the heavy selling to trade just below the flatline after Mizuho upgraded its price target on the stock to $825 from $625, as the chipmaker will continue its market dominance amid rising AI demand. 

The bullish backing comes come just ahead of the fourth-quarter results due Feb. 21. 

Nvidia is up 231% over the past year, with market cap of about $1.79 trillion.  

(Scott Kanowsky, Oliver Gray contributed to this report.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.